Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. The company offers features such as a proprietary data analytics engine that harmonizes extensive patient molecular profiles, identifies novel therapeutic targets, and develops diagnostics, enabling researchers and healthcare providers to create targeted therapies based on individual genetics, ultimately improving treatment outcomes for patients suffering from chronic conditions.
Developer of precision medicine in oncology designed to provide big data analysis in cancer. The company develops a cell-free liquid biopsy technology, enabling healthcare professionals to use minimally-invasive molecular diagnosis for treatment selection, therapy monitoring, and detection of cancer earlier.
Developer of a digital healthcare company designed to improve patient outcomes by generating insights from real-world data to support the discovery and development of new medicines. The company develops clinically validated software applications powered by artificial intelligence including prescribed digital therapeutics and hospital systems for clinical care that connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research companies to generate maximum revenue from the healthcare segment.